UroGen Pharma Ltd.

URGN chart

UroGen Pharma Ltd. news

• UroGen Pharma (URGN) Could Be 57% Undervalued On Strong Third Quarter Results

  Simply Wall St · Nov 9, 8:28 PM EST

• UroGen Pharma Ltd. (URGN) Seasonal returns chart - Yahoo Finance

  Yahoo Finance Singapore · Nov 7, 8:37 AM EST

• UroGen Pharma Ltd. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

  Simply Wall St · Nov 7, 7:35 AM EST

• 5 Best Small-Cap Value Stocks to Invest In Now

  Yahoo Finance · Nov 6, 11:11 AM EST

• H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $75

  Moomoo · Nov 5, 7:31 AM EST

• Oppenheimer reiterates Outperform on UroGen Pharma stock at $60

  Investing.com · Nov 5, 6:43 AM EST

• UroGen Pharma (NasdaqGM:URGN) Stock Forecast & Analyst Predictions

  Simply Wall St · Nov 5, 3:00 AM EST

• UroGen Pharma Ltd (URGN) (Q3 2026) Earnings Call Highlights: Zysturi's 35% Sequential Surge and ...

  Yahoo Finance · Nov 4, 10:09 PM EST

• UroGen Pharma Ltd. Q3 2026 Earnings Call Summary

  app.moby.co · Nov 4, 9:45 PM EST

• Earnings Beat Might Change The Case For Investing In UroGen Pharma (URGN)

  Yahoo Finance · Nov 4, 8:13 PM EST

• UroGen Pharma (URGN) Reports Strong Q3 2026 Revenue Growth, Shar

  GuruFocus · Nov 4, 7:10 PM EST

• Urogen Pharma Q3 Earnings Call Highlights

  marketbeat.com · Nov 4, 5:14 PM EST

UroGen Pharma Ltd. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-QFORM 10-Q2026-11-04
• 8-KFORM 8-K2026-11-04
• 8-KFORM 8-K2026-08-20
• 10-QFORM 10-Q2026-08-05
• 8-KFORM 8-K2026-08-05
• 8-KFORM 8-K2026-06-23
• 8-KFORM 8-K2026-06-02
• 10-QFORM 10-Q2026-05-06
• 8-KFORM 8-K2026-05-06
• DEF 14AFORM DEF 14A2026-04-30
• 10-KFORM 10-K2026-03-02
• 8-KFORM 8-K2026-03-02

About UroGen Pharma Ltd.

Ticker

URGN (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Ra'Anana, Israel

Incorporated in

Israel

Fiscal year end

December 31

SEC CIK

1668243

Frequently asked questions